Catamenial epilepsy: hormonal aspects

Alberto Verrotti, Melissa Laus, Giangennaro Coppola, Pasquale Parisi, Angelika Mohn, Francesco Chiarelli
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2010 · vol. 26(11) , pp. 783–790 · doi:10.3109/09513590.2010.490606 · PMID:20518639 · W1994503382
Review OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

Catamenial epilepsy, characterized by cyclical seizure exacerbations tied to menstrual phases, is driven by fluctuating proconvulsant estrogen and anticonvulsant progesterone levels and potentially altered antiepileptic drug concentrations.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The term catamenial epilepsy is used to describe the cyclical occurrence of seizure exacerbations during particular phases of menstrual cycle in women with preexisting epilepsy. Recent investigations have demonstrated the existence of at least three patterns of catamenial seizure exacerbation: perimenstrual and periovulatory in ovulatory cycle and entire luteal phase in anovulatory cycle. Cyclical changes in the circulating levels of estrogens (proconvulsant) and progesterone (anticonvulsant) play a central role in the development of catamenial epilepsy. Also, variations in concentrations of antiepileptic drugs across the menstrual cycle may contribute to increased seizure susceptibility. A variety of approaches have been proposed for the treatment of catamenial epilepsy.

My notes (saved in your browser only)

MeSH descriptors

Epilepsy Epilepsy Estrogens Menstrual Cycle Progesterone Adolescent Adult Anticonvulsants Anticonvulsants Anticonvulsants Epilepsy Epilepsy Epilepsy Estrogens Estrogens Female Humans Menstrual Cycle Menstrual Cycle Neurotransmitter Agents

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (93)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-10-08T21:07:39.929932+00:00
unpaywall
last seen: 2026-10-20T06:27:24.728081+00:00
License: CC0 · commercial use OK